Lilly declares third-quarter 2025 dividend

Group 1 - Eli Lilly and Company has declared a dividend of $1.50 per share for the third quarter of 2025, payable on September 10, 2025, to shareholders of record as of August 15, 2025 [1] - The company has been a pioneer in medicine for nearly 150 years, focusing on significant health challenges such as diabetes care, obesity treatment, Alzheimer's disease, immune system disorders, and difficult-to-treat cancers [2] - Eli Lilly aims to make life better for millions by advancing innovative clinical trials and ensuring the accessibility and affordability of its medicines [2] Group 2 - The company utilizes biotechnology, chemistry, and genetic medicine to drive its research and development efforts [2] - Eli Lilly's medicines currently help tens of millions of people globally [2] - The company is committed to reflecting the diversity of the world in its clinical trials [2]